| John J Orazietti, CRNA | |
|
267 Grant St, Bridgeport Anesthesia Associates, P.c., Bridgeport, CT 06610-2805 | |
| (203) 384-3072 | |
| Not Available |
| Full Name | John J Orazietti |
|---|---|
| Gender | Male |
| Speciality | Certified Registered Nurse Anesthetist (crna) |
| Experience | 22 Years |
| Location | 267 Grant St, Bridgeport, Connecticut |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1992816599 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367500000X | Nurse Anesthetist, Certified Registered | 002792 (Connecticut) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Bridgeport Hospital | Bridgeport, CT | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Yale University | 9436061736 | 2241 |
News Archive
A new study of coronary artery calcium scanning - a simple, noninvasive test that gives patients baseline information about plaque in their coronary arteries—has shown that the scan helps them make heart-healthy lifestyle changes and lower their heart disease risk factors.
A study conducted by UCSF Benioff Children's Hospital Oakland Research Institute scientists shows greatly improved protective antibody responses to a new mutant vaccine antigen for prevention of disease caused by Neisseria meningitidis - also known as meningococcus - that has the potential to improve the current vaccines for meningitis.
MONITORING FORCE GmbH announced that they have filed on November 16th, 2009 Flibanserin in the indication treatment-relevant levodopa-induced dyskinesia in Parkinson's disease for orphan drug status designation with the European Medicines Agency (EMEA). Levodopa-induced dyskinesia is a complication of the mainstay treatment in advanced Parkinson's and a serious burden to some of those affected, since it may be disabling for the patients and preventing them from receiving optimal treatment for Parkinson's.
New research that provides a better understanding of pancreatic cancer may help identify individuals at increased risk. The findings are published early online in Cancer, a peer-reviewed journal of the American Cancer Society.
Elsevier Business Intelligence, the medtech industry's leading strategic partner and investment conference organizer, hosted the year's largest annual strategic partnership and investment meeting, 'IN3 Medical Device Summit', on October 20-21 at San Francisco's InterContinental Mark Hopkins Hotel. This event followed Elsevier Business Intelligence's 'Medical Device Investor Day', also held at the InterContinental Mark Hopkins, on October 19.
› Verified 6 days ago
| Entity Name | Yale University |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1205822236 PECOS PAC ID: 9436061736 Enrollment ID: O20031105000015 |
News Archive
A new study of coronary artery calcium scanning - a simple, noninvasive test that gives patients baseline information about plaque in their coronary arteries—has shown that the scan helps them make heart-healthy lifestyle changes and lower their heart disease risk factors.
A study conducted by UCSF Benioff Children's Hospital Oakland Research Institute scientists shows greatly improved protective antibody responses to a new mutant vaccine antigen for prevention of disease caused by Neisseria meningitidis - also known as meningococcus - that has the potential to improve the current vaccines for meningitis.
MONITORING FORCE GmbH announced that they have filed on November 16th, 2009 Flibanserin in the indication treatment-relevant levodopa-induced dyskinesia in Parkinson's disease for orphan drug status designation with the European Medicines Agency (EMEA). Levodopa-induced dyskinesia is a complication of the mainstay treatment in advanced Parkinson's and a serious burden to some of those affected, since it may be disabling for the patients and preventing them from receiving optimal treatment for Parkinson's.
New research that provides a better understanding of pancreatic cancer may help identify individuals at increased risk. The findings are published early online in Cancer, a peer-reviewed journal of the American Cancer Society.
Elsevier Business Intelligence, the medtech industry's leading strategic partner and investment conference organizer, hosted the year's largest annual strategic partnership and investment meeting, 'IN3 Medical Device Summit', on October 20-21 at San Francisco's InterContinental Mark Hopkins Hotel. This event followed Elsevier Business Intelligence's 'Medical Device Investor Day', also held at the InterContinental Mark Hopkins, on October 19.
› Verified 6 days ago
| Entity Name | Bridgeport Anesthesia Associates, P.c. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1174549257 PECOS PAC ID: 7113824616 Enrollment ID: O20031215000038 |
News Archive
A new study of coronary artery calcium scanning - a simple, noninvasive test that gives patients baseline information about plaque in their coronary arteries—has shown that the scan helps them make heart-healthy lifestyle changes and lower their heart disease risk factors.
A study conducted by UCSF Benioff Children's Hospital Oakland Research Institute scientists shows greatly improved protective antibody responses to a new mutant vaccine antigen for prevention of disease caused by Neisseria meningitidis - also known as meningococcus - that has the potential to improve the current vaccines for meningitis.
MONITORING FORCE GmbH announced that they have filed on November 16th, 2009 Flibanserin in the indication treatment-relevant levodopa-induced dyskinesia in Parkinson's disease for orphan drug status designation with the European Medicines Agency (EMEA). Levodopa-induced dyskinesia is a complication of the mainstay treatment in advanced Parkinson's and a serious burden to some of those affected, since it may be disabling for the patients and preventing them from receiving optimal treatment for Parkinson's.
New research that provides a better understanding of pancreatic cancer may help identify individuals at increased risk. The findings are published early online in Cancer, a peer-reviewed journal of the American Cancer Society.
Elsevier Business Intelligence, the medtech industry's leading strategic partner and investment conference organizer, hosted the year's largest annual strategic partnership and investment meeting, 'IN3 Medical Device Summit', on October 20-21 at San Francisco's InterContinental Mark Hopkins Hotel. This event followed Elsevier Business Intelligence's 'Medical Device Investor Day', also held at the InterContinental Mark Hopkins, on October 19.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| John J Orazietti, CRNA 267 Grant St, Bridgeport Anesthesia Associates, P.c., Bridgeport, CT 06610-2805 Ph: (203) 384-3072 | John J Orazietti, CRNA 267 Grant St, Bridgeport Anesthesia Associates, P.c., Bridgeport, CT 06610-2805 Ph: (203) 384-3072 |
News Archive
A new study of coronary artery calcium scanning - a simple, noninvasive test that gives patients baseline information about plaque in their coronary arteries—has shown that the scan helps them make heart-healthy lifestyle changes and lower their heart disease risk factors.
A study conducted by UCSF Benioff Children's Hospital Oakland Research Institute scientists shows greatly improved protective antibody responses to a new mutant vaccine antigen for prevention of disease caused by Neisseria meningitidis - also known as meningococcus - that has the potential to improve the current vaccines for meningitis.
MONITORING FORCE GmbH announced that they have filed on November 16th, 2009 Flibanserin in the indication treatment-relevant levodopa-induced dyskinesia in Parkinson's disease for orphan drug status designation with the European Medicines Agency (EMEA). Levodopa-induced dyskinesia is a complication of the mainstay treatment in advanced Parkinson's and a serious burden to some of those affected, since it may be disabling for the patients and preventing them from receiving optimal treatment for Parkinson's.
New research that provides a better understanding of pancreatic cancer may help identify individuals at increased risk. The findings are published early online in Cancer, a peer-reviewed journal of the American Cancer Society.
Elsevier Business Intelligence, the medtech industry's leading strategic partner and investment conference organizer, hosted the year's largest annual strategic partnership and investment meeting, 'IN3 Medical Device Summit', on October 20-21 at San Francisco's InterContinental Mark Hopkins Hotel. This event followed Elsevier Business Intelligence's 'Medical Device Investor Day', also held at the InterContinental Mark Hopkins, on October 19.
› Verified 6 days ago
Caitlin Van Ess, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 2800 Main St, Bridgeport, CT 06606 Phone: 860-576-5000 | |
Kevin Traille, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 267 Grant St, Bridgeport, CT 06610 Phone: 203-384-3174 | |
Cleofas Espinoza, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 2800 Main St, Bridgeport, CT 06606 Phone: 203-576-6000 | |
Kelly Takacs, Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 2800 Main Street, Saint Vincents Medical Center, Bridgeport, CT 06606 Phone: 203-929-7353 Fax: 203-929-0756 | |
Tara Seiler, Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 280 Main St, St Vincents Medical Center, Bridgeport, CT 06604 Phone: 203-929-7353 Fax: 203-929-0756 | |
Peter Jakubowski, Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 2800 Main St, St Vincents Medical Center, Bridgeport, CT 06606 Phone: 203-929-7353 Fax: 203-929-0756 | |
Mrs. Marla Jean Peterson, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 267 Grant St, Bridgeport Hospital, Bridgeport, CT 06610 Phone: 203-384-3801 Fax: 203-384-4619 |